ArTS Archivio della ricerca di Trieste

FABRIS, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.248
EU - Europa 2.988
AS - Asia 1.173
SA - Sud America 30
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 9
Totale 10.479
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.221
IT - Italia 992
SE - Svezia 700
CN - Cina 484
HK - Hong Kong 419
DE - Germania 253
BG - Bulgaria 196
IE - Irlanda 162
UA - Ucraina 151
PL - Polonia 113
GB - Regno Unito 101
TR - Turchia 90
FI - Finlandia 79
CH - Svizzera 57
RU - Federazione Russa 39
FR - Francia 36
IN - India 36
VN - Vietnam 28
NL - Olanda 26
SG - Singapore 25
IR - Iran 23
JP - Giappone 23
KR - Corea 22
BE - Belgio 21
CA - Canada 21
SN - Senegal 17
BR - Brasile 16
RO - Romania 15
DK - Danimarca 10
AT - Austria 9
ES - Italia 9
EU - Europa 9
AU - Australia 7
AR - Argentina 6
MX - Messico 6
MY - Malesia 5
PE - Perù 4
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
SK - Slovacchia (Repubblica Slovacca) 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CL - Cile 2
CO - Colombia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GR - Grecia 2
ID - Indonesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
HU - Ungheria 1
JO - Giordania 1
KW - Kuwait 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
SM - San Marino 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 10.479
Salva come PNG Salva come JPEG
Città #
Fairfield 909
Chandler 668
Woodbridge 627
Ashburn 572
Wilmington 461
Houston 429
Seattle 426
Hong Kong 415
Ann Arbor 408
Cambridge 291
Princeton 259
Jacksonville 220
Trieste 208
Sofia 196
Beijing 194
Dublin 159
Warsaw 107
Izmir 71
Dearborn 63
San Diego 58
Boardman 57
Milan 53
Venezia 50
Bern 48
Helsinki 44
Rome 44
Grafing 38
Redwood City 34
Rostock 29
Dong Ket 26
Jinan 22
Des Moines 20
Washington 20
Bremen 18
Brussels 18
Turin 18
Dakar 17
Los Angeles 17
Redmond 16
Guangzhou 15
London 15
Monfalcone 15
Pune 15
Toronto 15
Falls Church 14
Naples 14
Shanghai 14
Brescia 13
Falkirk 13
Nanjing 13
Seoul 12
Tokyo 11
Andover 10
Bari 10
Hefei 10
Mykolayiv 10
Portici 10
Valenzano 10
Aarhus 9
Kocaeli 9
Kunming 9
Mumbai 9
Norwalk 9
Nuremberg 9
Palermo 9
Udine 9
Frankfurt am Main 8
São Paulo 8
Timisoara 8
Vienna 8
Asheville 7
Chicago 7
Padova 7
San Mateo 7
Cagliari 6
Dongguan 6
Duncan 6
Genoa 6
Hebei 6
Lappeenranta 6
Lucca 6
Menlo Park 6
San Francisco 6
Shenyang 6
Bergamo 5
Buenos Aires 5
Buffalo 5
Glasgow 5
Jungnang-gu 5
Mestre 5
Monterrey 5
Nanchang 5
New York 5
Paris 5
Phoenix 5
Sasso Marconi 5
Trento 5
Acireale 4
Ardabil 4
Berlin 4
Totale 7.838
Salva come PNG Salva come JPEG
Nome #
Iperpotassiemia nello scompenso cardiaco: nuove soluzioni per un vecchio problema 361
Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry 286
Consulenza cardiologica e gestione perioperatoria del paziente cardiopatico. Protocollo dell’Azienda Sanitaria Universitaria Integrata di Trieste – Anno 2019 222
Infiltrative/storage cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 205
Riabilitazione cardiologica ambulatoriale a Trieste: Protocolli, attività  ed esiti 202
Treatment of Functional Mitral Regurgitation in Heart Failure 202
Other cardiomyopathies: Clinical assessment and imaging in diagnosis and patient management 184
Preoperative Intra-Aortic Counterpulsation in Cardiac Surgery: Insights From a Retrospective Series of 588 Consecutive High-Risk Patients 183
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry 175
Balloon valvuloplasty after Transcatheter Aortic Valve Implantation (TAVI): always safe? 171
The role of clinical observation: Red flag 5-right ventricular involvement, arrhythmogenic right ventricular cardiomyopathy and associated phenotypes 169
Early Improvement of Functional Mitral Regurgitation in Patients With Idiopathic Dilated Cardiomyopathy 162
Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors 160
Coronary covered stents 158
Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. 152
The role of clinical observation: Red flag 1-cardiomyopathies and skeletal muscle involvement 147
Left ventricular noncompaction, morphological, and clinical features for an integrated diagnosis 146
Early occurrence of drug intolerance as risk factor during follow-up in patients with acute coronary syndrome or coronary revascularization 145
Prognostic Role of Left Ventricular Dysfunction in Patients With Coronary Artery Disease After an Ambulatory Cardiac Rehabilitation Program 142
Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy 141
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry 140
Clinical Echocardiography and Other Imaging Techniques in Cardiomyopathies 139
Cardiac Tumors: Diagnosis, Prognosis, and Treatment 139
Chapter 15: Dilated Cardiomyopathy at the Crossroad: Multidisciplinary Approach 138
null 135
Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: a long-term follow-up study 135
Bilateral coronary obstruction in high-risk transcatheter aortic valve-in-valve implantation: When procedural strategy counts 133
Left bundle branch block in dilated cardiomyopathy with intermediate left ventricular dysfunction: clinical phenotyping and outcome correlates 133
The role of clinical observation: red flag 8 - Cardiomyopathies in the first year of life and pediatric cardiomyopathies. 132
null 131
Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction 129
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry 127
Effect of early tirofiban administration on N-terminal pro-B-type natriuretic peptide level in patients treated with primary percutaneous coronary intervention 121
Cardiac hypertrophy, accessory pathway, and conduction system disease in an adolescent: the PRKAG2 cardiac syndrome. 119
Gender-related differences in heart failure: beyond the “one-size-fits-all” paradigm 119
Nonatherosclerotic Coronary Artery Narrowing 112
Impact of patient delay in a modern real world STEMI network 111
[Sudden cardiac death in patients with left ventricular dysfunction from ischemic heart disease: role of the implantable defibrillator. Evidence, guidelines and good clinical judgment]. 110
If heart failure or cardiac arrest complicate pregnancy and delivery 109
The evolution of cardiology: Changes, future challenges and opportunities 109
null 108
Is high pressure postdilation safe in bioresorbable vascular scaffolds? Optical coherence tomography observations after noncompliant balloons inflated at more than 24 atmospheres 106
Direct cellular reprogramming: the hopes and the hurdles 103
Accuracy of right atrial pressure estimation using a multi-parameter approach derived from inferior vena cava semi-automated edge-tracking echocardiography: a pilot study in patients with cardiovascular disorders 103
Viral presence-guided immunomodulation in lymphocytic myocarditis: an update 102
Calcific degeneration and rupture of the aortic valve and ascending aorta: From cardiac auscultation to multimodality imaging 101
Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy 100
Left bundle branch block-induced cardiomyopathy: a diagnostic proposal for a poorly explored pathological entity 96
Inflammation in cardiac amyloidosis: prognostic marker or therapeutic target? 95
Sacubitril/Valsartan: Updates and Clinical Evidence for a Disease-Modifying Approach 94
Three-vessel coronary artery disease evaluation by multimodality imaging with near-infrared spectroscopy (NIRS) plus intravascular ultrasound (IVUS) and optical coherence tomography (OCT) 92
Guide extension, unmissable tool in the armamentarium of modern interventional cardiology. A comprehensive review 90
La cardiomiopatia dilatativa non sempre è evolutiva: come evitare decisioni errate? 89
Clinical Spectrum of PRKAG2 Syndrome 86
Reliability of noninvasive hemodynamic assessment with Doppler echocardiography: comparison with the invasive evaluation 86
Optical coherence tomography for strategy planning and staged optimization of spontaneous coronary artery dissection 82
Prognostic relevance of pericardial effusion in STEMI patients treated by primary percutaneous coronary intervention: a 10-year single-centre experience 79
Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS 79
Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry 77
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world 77
Bioresorbable vascular scaffold radial expansion and conformation compared to a metallic platform: Insights from in vitro expansion in a coronary artery lesion model 74
Natural history of spontaneous coronary dissections 71
Insufficienza tricuspidale e indicazioni al trattamento 69
Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation 63
Intra-coronary Imaging for the Evaluation of Plaque Modifications Induced by Drug Therapies for Secondary Prevention 61
Effect of prehospital treatment in STEMI patients undergoing primary PCI 61
Supraventricular Tachycardia Causing Left Ventricular Dysfunction 59
Impact on clinical outcomes of right ventricular response to percutaneous correction of secondary mitral regurgitation 57
Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry 56
Hat-Marker Orientation to Minimize Neo-Commissural Overlap With Coronaries During CoreValve Evolut TAVR 55
Thoracic pain: Clinical features 55
Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation 54
Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study 53
Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial 49
Rimodellamento inverso nei pazienti con disfunzione ventricolare sinistra: predittori di miglioramento e revisione della letteratura 48
Antithrombotic therapy in heart failure and sinus rhythm: the ongoing search for a better match of patients to therapy 48
STEMI and Multivessel Disease: Medical Therapy Amplifies the Benefit of Complete Myocardial Revascularisation 48
Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience? 45
Combining New Classes of Drugs for HFrEF: from Trials to Clinical Practice 45
Right ventricular dysfunction in right coronary artery infarction: A primary PCI registry analysis 43
Pathogenesis 42
Cardiac amyloidosis: do not forget to look for it 42
Appropriateness and surroundings: "Doing more does not mean doing better". Choosing wisely, an unfulfilled commitment? 41
Bioabsorbable vascular scaffold overexpansion: Insights from in vitro post-expansion experiments 40
Endomyocardial fibrosis of the right ventricle: A case report of successful surgery 39
Early prognostic stratification and identification of irreversibly shocked patients despite primary percutaneous coronary intervention 39
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction 39
Appropriateness, inappropriateness and waste of resources: Unfulfilled expectations? 38
Angiography and electrocardiography (ECG) for the assessment of coronary microvascular obstruction 36
Endomyocardial biopsy in the clinical context: current indications and challenging scenarios 36
Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC Trial 35
Update 2022 dell’Expert Opinion della Società Italiana di Cardiologia su miocarditi, pericarditi e vaccini contro il COVID-19 34
Prognostic significance of atrial fibrillation and severity of symptoms of heart failure in patients with low gradient aortic stenosis and preserved left ventricular ejection fraction 34
Long-term mortality and prehospital tirofiban treatment in patients with ST elevation myocardial infarction 34
Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: Insights from the ATLANTIC trial 33
Assessment of BVS failure with intracoronary imaging. 33
Viral genome search in myocardium of patients with fulminant myocarditis 33
Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus 31
One-year mortality for bivalirudin vs heparins plus optional glycoprotein IIb/IIIa inhibitor treatment started in the ambulance for ST-segment elevation myocardial infarction a secondary analysis of the EUROMAX randomized clinical trial 29
Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials 29
Totale 9.910
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.081
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019357 0 0 0 0 0 0 0 0 0 0 230 127
2019/20201.895 70 63 72 226 91 198 179 173 203 386 139 95
2020/20212.358 95 123 135 532 303 224 228 121 101 194 109 193
2021/20221.650 69 104 64 70 122 153 76 65 227 142 160 398
2022/20232.229 216 295 256 264 163 387 40 141 257 38 128 44
2023/20241.599 106 95 76 119 147 231 292 390 29 112 2 0
Totale 11.115